Nov 6 (Reuters) - PYC Therapeutics Ltd (PYC) :
- HELD PRE-IND MEETING WITH US FDA AND AGREED ON PROPOSED PATHWAY THROUGH CLINICAL TRIALS FOR DRUG CANDIDATE
- ALIGNED WITH US FDA FOR CLINICAL TRIALS OF ITS INVESTIGATIONAL DRUG CANDIDATE FOR AUTOSOMAL DOMINANT OPTIC ATROPHY
- EXPECTS TO PROGRESS DRUG CANDIDATE TO HUMAN TRIALS IN 1H 2024
News: PYC PYC Therapeutics Holds Pre-IND Meeting With US FDA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.060(4.62%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $79.23K | 63.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96565 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 18318 | 9 |
View Market Depth
| Last trade - 15.00pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |